Clinical Trial Detail

NCT ID NCT03134131
Title Expanded Access Program for ONC201 to Treat Recurrent Histone H3 Mutant Glioma
Recruitment Temporarily not available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Oncoceutics, Inc.
Indications

malignant glioma

Therapies

ONC201

Age Groups: adult senior

No variant requirements are available.